Diagnostic Accuracy of Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Skeletal Metastasis in Patients of Breast CA in Comparison with Bone Scan
DOI:
https://doi.org/10.21649/akemu.v32i1.5977Keywords:
Bone scan, Diffusion weighted MRI, Breast CA, skeletal metastasisAbstract
Background: Breast carcinoma (CA) is one of the most prevalent cancers in women all across the globe. In current clinical practice, bone scan is main method for determining metastasis. However, use of various other imaging such as whole body magnetic resonance imaging (WB-MRI), enhanced with diffusion weighted protocol, can provide with a significant alternative method in early detection and assessment of various treatment options.
Objective: To evaluate diagnostic accuracy of diffusion weighted MRI (DW-MRI) for skeletal metastasis in patients of breast CA taking bone scan as a gold standard.
Methods: It was a cross sectional study, carried out at Department of Radiology, Mayo Hospital Lahore. 106 patients were enrolled and sent to the department of nuclear medicine for bone scan as part of their routine bone metastatic work-up. MRI including conventional sequences as well as DW sequence was then performed in all patients.
Results: Mean age of patients was 51.2±11.7 years. On bones scan, metastasis were identified in 86 (81.1%) patients, while it was negative in 20 (18.2 %) patients. On DWI, metastatic disease was found in 73 (68.8%) patients, while it was absent in 33(31.1%) patients. Sensitivity, specificity, PPV and NPV of DWI-MRI were 80.1%, 80.0%, 94.5% and 48.4%, respectively.
Conclusion: Sensitivity and specificity values of DWI are satisfactorily high in detecting metastatic disease in patients of breast CA. It can be a reliable and noninvasive alternate in detection of early disease.
References
1. Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies - an updated review. Cancers (Basel). 2021;13 (17):4287. doi:10.3390/cancers1317487
2. Khan NH, Duan SF, Wu DD, Ji XY. Better reporting and awareness campaigns needed for breast cancer in Pakistani women. Cancer Manag Res. 2021;13 (3):2125–9. doi:10.2147/CMAR.S270671
3. Tufail M, Wu C. Exploring the burden of cancer in Pakistan: an analysis of 2019 data. J Epidemiol Glob Health. 2023;13 (2):333–43. doi:10.1007/s44197-023-00104-5
4. Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast cancer statistics, 2022. CA Cancer J Clin. 2022;72 (10):524–41. doi:10.3322/caac.21754
5. Pang L, Gan C, Xu J, Jia Y, Chai J, Huang R, et al. Bone metastasis of breast cancer: molecular mechanisms and therapeutic strategies. Cancers (Basel). 2022;14(23):5727. doi:10.3390/cancers14235727
6. Marazzi F, Orlandi A, Manfrida S, Masiello V, Di Leone A, Massaccesi M, et al. Diagnosis and treatment of bone metastases in breast cancer: radiotherapy, local approach and systemic therapy in a guide for clinicians. Cancers (Basel). 2020;12(9):2390. doi:10.3390/cancers12092390
7. Papandrianos N, Papageorgiou E, Anagnostis A, Papageorgiou K. Efficient bone metastasis diagnosis in bone scintigraphy using a fast convolutional neural network architecture. Diagnostics (Basel). 2020;10(8):532. doi:10.3390/diagnostics10080532
8. Cook GJR. Imaging of bone metastases in breast cancer. Semin Nucl Med. 2022;52(2):531–41. doi:10.1053/j.semnuclmed.2022.01.005
9. Lee SH, Shin HJ, Moon WK. Diffusion-weighted magnetic resonance imaging of the breast: standardization of image acquisition and interpretation. Korean J Radiol. 2021;22(1):9–22. doi:10.3348/kjr.2020.0093
10. Gullo RL, Partridge SC, Shin HJ, Thakur SB, Pinker K. Update on DWI for breast cancer diagnosis and treatment monitoring. Am J Roentgenol. 2024;222(1):e2329933. doi:10.2214/AJR.23.29933
11. Gerke O, Naghavi-Behzad M, Nygaard ST, Sigaroudi VR, Vogsen M, Vach W, et al. Diagnosing bone metastases in breast cancer: a systematic review and network meta-analysis on diagnostic test accuracy studies of 2-[18F] FDG-PET/CT, 18F-NaF-PET/CT, MRI, contrast-enhanced CT, and bone scintigraphy. Semin Nucl Med. 2025;55(1):137–51. doi:10.1053/j.semnuclmed.2024.10.008
12. O’Sullivan GJ, Carty FL, Cronin CG. Imaging of bone metastasis: an update. World J Radiol. 2015;7(8):202–11. doi:10.4329/wjr.v7.i8.202
13. Agrawal A, Purandare N, Shah S, Rangarajan V. Metastatic mimics on bone scan: “all that glitters is not metastatic.” Indian J Nucl Med. 2016;31(3):185–90. doi:10.4103/0972-3919.183605
14. Fliedner FP, Engel TB, El-Ali HH, Hansen AE, Kjaer A. Diffusion weighted magnetic resonance imaging (DW-MRI) as a non-invasive tissue cellularity marker to monitor cancer treatment response. BMC Cancer. 2020;20(1):134. doi:10.1186/s12885-020-6617-x
15. Paruthikunnan SM, Kadavigere R, Karegowda LH. Accuracy of whole-body DWI for metastases screening in a diverse group of malignancies: comparison with conventional cross-sectional imaging and nuclear scintigraphy. Am J Roentgenol. 2017;209(3):477–90. doi:10.2214/AJR.17.17829
16. Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2021;124(1):13–26. doi:10.1038/s41416-020-01161-4
17. Stecco A, Trisoglio A, Soligo E, Berardo S, Sukhovei L, Carriero A. Whole-body MRI with diffusion-weighted imaging in bone metastases: a narrative review. Diagnostics (Basel). 2018;8(3):45-56. doi:10.3390/diagnostics8030045
18. Rong Y, Ren H, Ding X. MRI and bone scintigraphy for breast cancer bone metastases: a meta-analysis. Open Med (Wars). 2019;14(3):317–23. doi:10.1515/med-2019-0029
19. Takenaka D, Ohno Y, Matsumoto K, Aoyama N, Onishi Y, Koyama H, et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging, whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging. 2009;30(2):298–308. doi:10.1002/jmri.21858
20. Jambor I, Kuisma A, Ramadan S, Huovinen R, Sandell M, Kajander S, et al. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole-body 1.5T MRI including DWI for detection of bone metastases in high-risk breast and prostate cancer patients: SKELETA clinical trial. Acta Oncol. 2016;55(1):59–67. doi:10.3109/0284186X.2015.1027411
21. Frank S, Carton M, Dubot C, Campone M, Pistilli B, Dalenc F, et al. Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort. Breast. 2020;52(8):50–7. doi:10.1016/j.breast.2020.04.009
22. Rezk M, Nasr I, Ali I, Abdelhamed H. Comparative study between 18F-FDG PET/CT and whole-body MRI DWIBS in assessment of recurrent breast cancer: a prospective comparative cross-sectional study. Indian J Nucl Med. 2019;34(1):1–9. doi:10.4103/ijnm.IJNM_121_18
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Annals of King Edward Medical University
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments publications@kemu.edu.pk